Register entry

Alcon Laboratories, Inc

Data as of · How to read this entry

Registered sites
3
Active NDC listings
54
Labeller names
3
Live patents
61
Exclusivities
1
Countries
2
Base
United States
Authorisation

Registered operations

Finished drug manufacture2Relabelling1Repackaging2
Sites

Registered establishments

3
EstablishmentAddressRegistered forFEI / DUNS
Alcon Singapore Manufacturing Pte. Ltd.Registrant: Alcon Laboratories, Inc19 Tuas South Avenue 14, SG, 637313, Singapore (SGP)Finished drug manufacture3010372291595170137
Alcon Vision, LLCRegistrant: Alcon Laboratories, Inc6740 Business Parkway, Elkridge, Maryland (MD) 21075, United States (USA)Repackaging3000215259835979527
Alcon Research LLCRegistrant: Alcon Laboratories, Inc6201 South Freeway, Fort Worth, Texas (TX) 76134, United States (USA)Finished drug manufacture, Relabelling, Repackaging1610287007672236
Catalogue

Drug listings by form and route

54

54 active NDC listings: 30 human otc drug, 23 human prescription drug, 1 bulk ingredient. By marketing category: OTC MONOGRAPH DRUG 25, NDA 20, ANDA 8, BULK INGREDIENT 1.

Dosage formNDCs
solution/ drops23
solution12
emulsion7
gel4
kit2
ointment2
suspension/ drops2
injection, solution1
powder1
RouteNDCs
ophthalmic51
topical3
Labeller name on the listingNDCs
alcon laboratories, inc.52
alcon laboratories, inc.1
alcon, inc.1
Exclusivity

Patents and exclusivities

61
PatentProductCoversExpiry
10174017RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylatesubstance, productJan 2030
10654844RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylatesubstance, productJan 2030
11028081RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylateuseJan 2030
11618748RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylateuseJan 2030
9421265SIMBRINZAbrimonidine tartrate; brinzolamideproductJun 2030
9044484SIMBRINZAbrimonidine tartrate; brinzolamideproductOct 2030
8394826RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylatesubstance, productNov 2030
10028920TRYPTYRacoltremonuseSept 2031
9095609TRYPTYRacoltremonproductSept 2031
9433679TRYPTYRacoltremonuseSept 2031
8791154PATADAY ONCE DAILY RELIEFolopatadine hydrochlorideproductMay 2032
9533053PATADAY ONCE DAILY RELIEFolopatadine hydrochlorideproductMay 2032
10058511EYSUVIS, INVELTYSloteprednol etabonateproductMay 2033
10646436EYSUVISloteprednol etabonateproductMay 2033
10646437INVELTYSloteprednol etabonateproductMay 2033
10688045EYSUVIS, INVELTYSloteprednol etabonateproductMay 2033
10857096EYSUVISloteprednol etabonateuseMay 2033
10864219INVELTYSloteprednol etabonateuseMay 2033
10940108EYSUVISloteprednol etabonateuseMay 2033
10945948EYSUVISloteprednol etabonateuseMay 2033
10993908EYSUVISloteprednol etabonateuseMay 2033
11219596EYSUVISloteprednol etabonateuseMay 2033
11219597INVELTYSloteprednol etabonateuseMay 2033
11596599EYSUVISloteprednol etabonateuseMay 2033
11642317EYSUVIS, INVELTYSloteprednol etabonateproductMay 2033
11872318EYSUVIS, INVELTYSloteprednol etabonateproductMay 2033
12115246EYSUVIS, INVELTYSloteprednol etabonateproductMay 2033
9056057EYSUVIS, INVELTYSloteprednol etabonateproductMay 2033
9393213EYSUVIS, INVELTYSloteprednol etabonateproductMay 2033
9532955EYSUVIS, INVELTYSloteprednol etabonateuseMay 2033
9737491EYSUVIS, INVELTYSloteprednol etabonateuseMay 2033
9827191EYSUVIS, INVELTYSloteprednol etabonateproductMay 2033
10588901RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylatesubstance, productMar 2034
11020385RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylateuseMar 2034
11185538RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylateproductMar 2034
11197853ROCKLATANlatanoprost; netarsudil dimesylateproductMar 2034
9415043RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylatesubstanceMar 2034
9931336RHOPRESSA, ROCKLATANlatanoprost; netarsudil dimesylate; netarsudil mesylatesubstance, productMar 2034
9993470ROCKLATANlatanoprost; netarsudil dimesylatesubstance, productMar 2034
11850221TRYPTYRacoltremonproductDec 2042
12336971TRYPTYRacoltremonuseDec 2042
ProductExclusivityUntil
TRYPTYRACOLTREMONNCE New chemical entityMay 2030
Catalogue

Marketed products

56

Showing 54 of 56.

BrandGeneric nameForm / routeNDC
Alcaineproparacaine hydrochloridesolution/ drops, ophthalmic0998-0016ANDA
Alcon Tears Lubricant Eye Dropshypromellose 2910solution/ drops, ophthalmic0065-0408OTC MONOGRAPH DRUG
BION TEARSDextran, Hypromellosesolution/ drops, ophthalmic0065-0419OTC MONOGRAPH DRUG
BION TEARSDextran, Hypromellosesolution/ drops, ophthalmic0065-9305OTC MONOGRAPH DRUG
BSSbalanced salt solutionsolution, ophthalmic0065-0795NDA
BSSbalanced salt solutionsolution, ophthalmic0065-1795NDA
BSS PLUSbalanced salt solution enriched with bicarbonate, dextrose, and glutathionekit0065-0800NDA
Betadinepovidone-iodinesolution, ophthalmic0065-0411NDA
Cyclogylcyclopentolate hydrochloridesolution/ drops, ophthalmic0065-0395ANDA
Cyclogylcyclopentolate hydrochloridesolution/ drops, ophthalmic0065-0396ANDA
Cyclogylcyclopentolate hydrochloridesolution/ drops, ophthalmic0065-0397ANDA
Cyclomydrilcyclopentolate hydrochloride and phenylephrine hydrochloridesolution/ drops, ophthalmic0065-0359ANDA
Eysuvisloteprednol etabonatesuspension/ drops, ophthalmic71571-333NDA
FLUORESCITEfluorescein sodiuminjection, solution, ophthalmic0065-0092NDA
GenTeal Tears (Moderate)Dextran 70, Glycerin, Hypromellosesolution/ drops, ophthalmic0065-0426OTC MONOGRAPH DRUG
GenTeal Tears Gel Dropspolyethylene glycol 400 and propylene glycolgel, ophthalmic0065-8067OTC MONOGRAPH DRUG
GenTeal Tears Moderate Preservative Freedextran 70, hypromellose 2910solution/ drops, ophthalmic0065-8063OTC MONOGRAPH DRUG
GenTeal Tears NIGHT-TIMEmineral oil, white petrolatumointment, ophthalmic0065-0518OTC MONOGRAPH DRUG
GenTeal Tears SevereHypromellosegel, ophthalmic0065-8064OTC MONOGRAPH DRUG
Isopto Atropineatropine sulfatesolution, ophthalmic0065-0303NDA
MIOSTATcarbacholsolution, ophthalmic0065-0023NDA
Mydriacyltropicamidesolution/ drops, ophthalmic0065-0355ANDA
Mydriacyltropicamidesolution/ drops, ophthalmic0998-0355ANDA
-NETARSUDIL MESYLATEpowder70727-324BULK INGREDIENT
Naphcon Anaphazoline hydrochloride and pheniramine maleatesolution/ drops, ophthalmic0065-0085NDA
PATADAY ONCE DAILY RELIEFOLOPATADINE HYDROCHLORIDEsolution, ophthalmic0065-0816NDA
PATADAY ONCE DAILY RELIEFOLOPATADINE HYDROCHLORIDEsolution, ophthalmic0065-8150NDA
PATADAY TWICE A DAY RELIEFOLOPATADINE HYDROCHLORIDEsolution, ophthalmic0065-4274NDA
Phenylephrine HydrochloridePhenylephrine Hydrochloridesolution/ drops, ophthalmic0065-0343NDA
Phenylephrine HydrochloridePhenylephrine Hydrochloridesolution/ drops, ophthalmic0065-0349NDA
Rhopressanetarsudilsolution/ drops, ophthalmic, topical70727-497NDA
Rocklatannetarsudil and latanoprost ophthalmic solution, 0.02%/0.005%solution/ drops, ophthalmic, topical70727-529NDA
SIMBRINZAbrinzolamide/brimonidine tartratesuspension/ drops, ophthalmic0065-4147NDA
SYSTANE HYDRATION PF PRESERVATIVE FREEPolyethylene Glycol 400 and Propylene Glycolsolution/ drops, ophthalmic0065-1437OTC MONOGRAPH DRUG
SYSTANE HYDRATION PF PRESERVATIVE FREEPolyethylene Glycol 400 and Propylene Glycolsolution/ drops, ophthalmic0065-1510OTC MONOGRAPH DRUG
Systanepolyethylene glycol 400 and propylene glycolgel, ophthalmic0065-0454OTC MONOGRAPH DRUG
Systanehypromellosegel, ophthalmic0065-0474OTC MONOGRAPH DRUG
Systane Balancepropylene glycolemulsion, ophthalmic0065-1433OTC MONOGRAPH DRUG
Systane COMPLETEpropylene glycolemulsion, ophthalmic0065-0481OTC MONOGRAPH DRUG
Systane COMPLETE PFpropylene glycolemulsion, ophthalmic0065-1509OTC MONOGRAPH DRUG
Systane COMPLETE PFpropylene glycolemulsion, ophthalmic0065-1530OTC MONOGRAPH DRUG
Systane Complete PFPropylene Glycol Emulsionemulsion, ophthalmic0065-2509OTC MONOGRAPH DRUG
Systane Day and Night Value PackPolyethylene Glycol 400, Propylene Glycol 0.3%kit0065-1502OTC MONOGRAPH DRUG
Systane Lubricantpolyethylene glycol 400 and Propylene Glycolsolution/ drops, ophthalmic0065-0429OTC MONOGRAPH DRUG
Systane Nighttimemineral oil and white petrolatumointment, ophthalmic0065-0509OTC MONOGRAPH DRUG
Systane Pro PFPropylene Glycolemulsion, ophthalmic0065-3290OTC MONOGRAPH DRUG
Systane Pro PFPropylene Glycolemulsion, ophthalmic0065-9308OTC MONOGRAPH DRUG
Systane ULTRApolyethylene glycol 400 and propylene glycolsolution/ drops, ophthalmic0065-1432OTC MONOGRAPH DRUG
Systane UltraPolyethylene Glycol 400 and Propylene Glycolsolution/ drops, ophthalmic0065-1431OTC MONOGRAPH DRUG
Systane Ultra Preservative FreePolyethylene Glycol 400 and Propylene Glycolsolution/ drops, ophthalmic0065-1507OTC MONOGRAPH DRUG
TRYPTYRAcoltremonsolution, ophthalmic, topical0065-8595NDA
Tetracaine Hydrochloridetetracaine hydrochloridesolution, ophthalmic0065-0741NDA
Zaditorketotifen fumaratesolution, ophthalmic0065-4011ANDA
atropine sulfateatropine sulfatesolution, ophthalmic0065-0817NDA
Neighbours

Registered in the same town

8
Compare

Comparable companies in United States

Enquiry

Common questions

Is Alcon Laboratories, Inc FDA approved?
Alcon Laboratories, Inc holds 3 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Alcon Laboratories, Inc's drugs manufactured?
At registered sites in Singapore, the United States. The FDA register lists SG; Elkridge, MD; Fort Worth, TX. Registered operations: finished drug manufacture, relabelling, repackaging.
What drugs does Alcon Laboratories, Inc make?
56 products are listed under Alcon Laboratories, Inc in the openFDA NDC Directory, most often as solution/ drops; solution; emulsion. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.